A Study of Switching to RPV Plus Other ARVs in HIV-1-infected Children (Aged 2 to <12 Years) Who Are Virologically Suppressed

Inclusion Criteria: * Weighing at least 10 kilogram (kg) at screening * Have documented chronic Human Immunodeficiency Virus (HIV-1) infection * On a stable antiretroviral (ARV) regimen for at least 6 months prior to screening and virologically suppressed with documented evidence of at least 2 plasma viral loads less than (\<) 50 HIV-1 ribonucleic acid (RNA) copies/milliliter (mL): one within 2-12 months prior to screening and one at screening * Can switch from any ARV class * Never been treated with a therapeutic HIV vaccine * Historical HIV-1 genotyping result at screening for children aged \>=2 to \<6 years (and for children aged \>=6 to \<12 years if a historical HIV-1 genotyping result is available at screening) must demonstrate sensitivity to RPV and to the selected background ARVs Exclusion Criteria: * Have previously documented HIV-2 infection * Have known or suspected acute (primary) HIV-1 infection * Taken any disallowed concomitant therapies within 4 weeks before the planned first dose of study intervention * Any current or history of adrenal disorder * A history of virologic failure to ARVs with or without availability of an HIV-1 genotype result at the time of failure